Industry news that matters to you.  Learn more

Archives for April 2012

Affymetrix to Distribute Almac Xcel Array for Biomarker Discovery and Development

Almac announced last week that it has signed an exclusive global distribution agreement with Affymetrix to directly sell the company’s proprietary Xcel array for biomarker discovery, development and delivery worldwide.

DiaGenic and GE Healthcare to Develop Blood-based Test for Mild Cognitive Impairment

DiaGenic ASA [OSL:DIAG] recently announced a research agreement to collaborate with GE Healthcare to develop a blood-based test using DiaGenic’s peripheral gene expression profiling in patients with mild cognitive impairment, a disorder associated with risk for Alzheimer’s Disease. The study would be used in conjunction with PET imaging to identify a blood based gene expression signature in these patients. The PET imaging agent, [18F] Flutemetamol, is currently in phase 3 development and is not yet approved by any regulatory authority.